Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

McCormick's underlying execution improved through the second quarter of fiscal 2026: organic sales grew 1.7%, adjusted operating income rose 30.1%, and adjusted gross margin reached 40.2%. Management retained fiscal-year guidance for 1% to 3% organic growth, 16% to 20% adjusted operating-income growth, and adjusted EPS of $3.05 to $3.13. The proposed Unilever Foods combination offers substantial scale, geographic reach, and $600 million of targeted annual run-rate cost synergies, but it also introduces approval, financing, integration, dilution, and leverage risks.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets13 analysts · as of 18 Aug 2026
Low · most bearish analyst$52.00
Mean target$60.62
High · most bullish analyst$75.00
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$52.0025%

Consumer volume pressure persists, inflation and geopolitical freight costs erode underlying margin progress, or fiscal 2026 organic growth and adjusted operating-income growth fall below guidance. Regulatory conditions, financing costs, separation complexity, or integration disruption delay or impair the Unilever Foods transaction, while closing leverage above the announced ceiling reduces strategic flexibility.

Base CaseCentral scenario
$60.6255%
Matches the consensus mean

Fiscal 2026 results remain broadly within management's reaffirmed ranges, with acquisition-led reported growth and modest positive organic growth offset by continued softness in Consumer volume and mix. The Unilever Foods transaction advances toward a mid-2027 close, but financing and integration uncertainty limit conviction until detailed filings, approvals, and synergy milestones become available.

Bull CaseUpside scenario
$75.0020%

Organic growth reaches the upper half of fiscal 2026 guidance, Consumer volumes recover, and Flavor Solutions retains its improved momentum. The Unilever Foods transaction closes by mid-2027 without onerous remedies, and integration remains credible against the announced $600 million year-three cost-synergy target, 23% to 25% year-three operating-margin objective, and planned reduction of net leverage to 3.0 times within two years after closing.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter fiscal 2026 organic sales grew 1.7%, adjusted operating income increased 30.1%, and adjusted gross margin expanded materially even after excluding the tariff-refund benefit.
  • The proposed Unilever Foods combination would create a substantially larger global flavor platform and targets $600 million of annual run-rate cost synergies net of growth reinvestment.
  • McCormick maintained its $0.48 quarterly dividend in June 2026, continuing 102 consecutive years of dividend payments.
Sign in / Sign up to read more
Key Investment Risks
  • Consumer-segment volume and product mix declined 1.9% in the second quarter, showing that pricing rather than volume drove its organic growth.
  • The Unilever Foods transaction requires shareholder and regulatory approvals and entails a $15.7 billion cash payment, substantial new financing, and expected closing net leverage of up to 4.0 times.
  • The transaction depends on a complex separation and global integration, with announced synergy, margin, and deleveraging objectives that remain forward-looking.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.